U.S. GoldMining Inc. reported $14.33 million net loss as exploration spending rose to $10.97 million, leaving $1.06 million cash and substantial doubt about continuing operations. It later raised approximately $2 million through 408,163 shares in a direct offering.
USGO · U.S. GoldMining Inc. · Documents
Substantial doubt about the company's ability to continue as a going concern.
“As such, these events and conditions raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Nov 10, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
U.S. GoldMining Inc. agreed to sell 408,163 common shares at $4.90 per share for gross proceeds of approximately $1,999,998.70. The offering is expected to close on or about November 9, 2026; net proceeds are planned for working capital and general corporate purposes.
U.S. GoldMining Inc. appointed John DeLucchi to fill a board vacancy and chair its Audit Committee on November 2, 2026, regaining compliance with Nasdaq Listing Rule 5605.
U.S. GoldMining says the U.S. Army Corps of Engineers is evaluating AIDEA's Section 404 permit application for the West Susitna Access Project, and has qualified it for emergency permitting procedures.
U.S. GoldMining Inc. disclosed a consolidated net loss of (30,675) and exploration expenses of 16,125 for the nine months ended August 31, 2026. Cash and cash equivalents were 16,675 as at August 31, 2026.
U.S. GoldMining completed its 2026 surface exploration program at its 100% owned Whistler Gold-Copper Project, identifying new mineralized outcrop zones and expanding the high-priority drill-target pipeline; assays for 58 rock grab samples are pending.
U.S. GoldMining Inc. completed its 2026 exploration program at the 100% owned Whistler Gold-Copper Project, targeting high-priority porphyry centers; initial assay results are anticipated in the coming weeks and through to the end of 2026.